Literature DB >> 26823900

Pulmonary arterial hypertension due to pulmonary vascular amyloid deposition in a patient with multiple myeloma.

Hirotsugu Hashimoto1, Atsushi Kurata2, Hideaki Mizuno3, Tamaki Nashiro4, Akira Hangaishi3, Masahiko Kuroda2, Kensuke Usuki3, Hajime Horiuchi4.   

Abstract

Systemic amyloidosis is characterized by amyloid deposition throughout the body and subsequent dysfunction of various organs. Although pulmonary amyloidosis does occur, pulmonary hypertension (PH) caused by amyloidosis is extremely rare. In most of these cases, amyloid deposition occurred diffusely in alveolar septa, indicating that PH was due to lung disease and/or hypoxia. On the other hand, the mechanism of PH due to amyloid deposition in the pulmonary arteries has never been demonstrated. Here, we report the first case of PH due to amyloid deposition in pulmonary elastic arteries and muscular artery, which was complicated by multiple myeloma (MM). In the autopsy specimen of the patient, amyloid deposition was found mainly in the pulmonary arterial media, along with intimal thickening with luminal narrowing. PH thus appeared to be caused by marked decrease of pulmonary elasticity due to the amyloid deposition in the arterial media that resulted in stasis of the blood flow and subsequent luminal narrowing. Our present data demonstrates a new concept of PH caused by amyloidosis, namely, pulmonary arterial hypertension due to amyloidosis.

Entities:  

Keywords:  AL amyloidosis; multiple myeloma; pulmonary arterial hypertension; pulmonary artery

Mesh:

Substances:

Year:  2015        PMID: 26823900      PMCID: PMC4713686     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  13 in total

Review 1.  Hemodynamics for medical students.

Authors:  H S Badeer
Journal:  Adv Physiol Educ       Date:  2001-12       Impact factor: 2.288

2.  Pulmonary hypertension in patients with amyloidosis.

Authors:  D Dingli; J P Utz; M A Gertz
Journal:  Chest       Date:  2001-11       Impact factor: 9.410

3.  Pulmonary hypertension as a dominant clinical picture in a case of amyloidosis and smoldering multiple myeloma.

Authors:  Jukka Lehtonen; Pasi Kettunen
Journal:  Int J Cardiol       Date:  2006-10-17       Impact factor: 4.164

Review 4.  Updated clinical classification of pulmonary hypertension.

Authors:  Gerald Simonneau; Michael A Gatzoulis; Ian Adatia; David Celermajer; Chris Denton; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; R Krishna Kumar; Michael Landzberg; Roberto F Machado; Horst Olschewski; Ivan M Robbins; Rogiero Souza
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

5.  Right heart failure as the dominant clinical picture in a case of primary amyloidosis affecting the pulmonary vasculature.

Authors:  A D Chapman; P A Brown; K M Kerr
Journal:  Scott Med J       Date:  1999-08       Impact factor: 0.729

6.  Pulmonary hypertension from prominent vascular involvement in diffuse amyloidosis.

Authors:  S T Shiue; D P McNally
Journal:  Arch Intern Med       Date:  1988-03

7.  Right ventricular cardiac failure and pulmonary hypertension in a long-term dialysis patient--unusual presentation of visceral beta 2-microglobulin amyloidosis.

Authors:  A E Lutz; U Schneider; G Ehlerding; H Frenzel; K M Koch; K Kühn
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

8.  Common variable immunodeficiency and pulmonary amyloidosis: a case report.

Authors:  Sevket Arslan; Ramazan Ucar; Dudu Mehmet Yavsan; Hasan Esen; Emin Maden; Ismail Reisli; Ahmet Zafer Calıskaner
Journal:  J Clin Immunol       Date:  2015-03-14       Impact factor: 8.317

9.  Pulmonary hypertension and familial Mediterranean fever: a previously unrecognized association.

Authors:  W J Johnson; J T Lie
Journal:  Mayo Clin Proc       Date:  1991-09       Impact factor: 7.616

Review 10.  Pulmonary hypertension and amyloidosis--an uncommon association: a case report and review of the literature.

Authors:  Lihi Eder; Devy Zisman; Raffael Wolf; Haim Bitterman
Journal:  J Gen Intern Med       Date:  2007-03       Impact factor: 5.128

View more
  3 in total

1.  Gamma heavy chain disease complicated by pulmonary hypertension, which was successfully treated with lenalidomide.

Authors:  Sho Shibata; Akiko Fukunaga
Journal:  BMJ Case Rep       Date:  2020-11-30

2.  Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia.

Authors:  Indranee Rajapreyar; Joanna Joly; Jose Tallaj; Salpy V Pamboukian; Ayman Haj Assad; Carrie Lenneman; Silvio Litovsky; Arka Chatterjee; Charles Hoopes; Andrew Lenneman
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-11-20

3.  Pulmonary amyloidosis as the presenting finding in a patient with multiple myeloma.

Authors:  Ryan Kronen; David R Ziehr; Ashley E D Kane; Paul A VanderLaan; Cyrus A Kholdani; Robert W Hallowell
Journal:  Respir Med Case Rep       Date:  2022-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.